2025-12-19 - Analysis Report
Okay, here's a comprehensive report on Lam Research (LRCX) based on the provided data, followed by an analysis:

**Lam Research Corp (LRCX) Report**

**0) Overview**

*   Ticker: LRCX
*   Company: Lam Research Corp
*   Overview: Lam Research Corp supplies wafer fabrication equipment and services to the semiconductor industry.

**1) Return Rate Comparison**

*   **LRCX Cumulative Return:** 242.86%
*   **VOO (S&P 500) Cumulative Return:** 99.09%
*   **Divergence:**
    *   Current Divergence: 140.1
    *   Minimum Divergence: -15.5
    *   Maximum Divergence: 148.4
    *   Relative Divergence: 94.9

**Analysis:** Lam Research has significantly outperformed the S&P 500 (VOO) over the analyzed period. The current divergence is near its historical maximum, suggesting a period of strong relative performance by LRCX. The relative divergence of 94.9 indicates that the current outperformance is near the top of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 84.0% | 67.8% | 56.0% | 0.0 | 23.2 |
| 2016-2018  | 18.0% | 68.1% | 3.0% | 0.1 | 17.2 |
| 2017-2019  | 53.0% | 82.9% | 31.0% | 1.2 | 36.9 |
| 2018-2020  | 66.0% | 82.9% | 42.0% | 1.1 | 59.5 |
| 2019-2021  | 119.0% | 82.9% | 73.0% | 1.0 | 90.7 |
| 2020-2022  | -10.0% | 79.2% | -9.0% | 0.9 | 53.0 |
| 2021-2023  | -13.0% | 80.4% | -15.0% | 1.0 | 98.8 |
| 2022-2024  | -52.0% | 80.4% | -72.0% | 1.0 | 91.1 |
| 2023-2025  | 154.0% | 80.4% | 90.0% | 0.9 | 207.7 |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) varies significantly, showing periods of high growth (e.g., 2015-2017, 2019-2021, 2023-2025) and periods of decline (2020-2024).
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant volatility.
*   **Alpha:** Alpha, representing the excess return compared to the benchmark, is generally positive during growth periods and negative during declines, which makes sense.
*   **Beta:** Beta is around 1, suggesting that LRCX's price moves roughly in line with the market, although some periods see a higher beta (1.1-1.2) indicating slightly higher volatility than the overall market
*   **Cap(B):** Market capitalization has seen strong growth, reflecting the overall positive performance of the company over the long term, recently jumping from 91.1 to 207.7.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 164.70
*   **Previous Close:** 154.98
*   **Change:** 6.27
*   **5-day SMA:** 161.55
*   **20-day SMA:** 157.996
*   **60-day SMA:** 151.4038

**Analysis:** The stock is trading above its 5-day, 20-day, and 60-day Simple Moving Averages (SMAs), which is generally a bullish signal. The recent price change indicates a strong upward movement.

**3) Indicator Analysis**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment Recommended)
*   **RSI:** 58.30
*   **PPO:** -0.1431
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent Relative Divergence Change:** -3.7 (Short-term Decrease)
*   **Expected Return:** 16.1%

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is slightly below 70, suggesting it's not overbought.
*   The PPO is negative, indicating that the short-term moving average is below the long-term moving average, but the value is close to 0.
*   The Hybrid Signal recommends buying with most of available cash.
*   The recent decrease in relative divergence suggests a short-term downward trend in outperformance.
*   The expected return is quite high.

**4) Recent News & Significant Events**

*   **Positive News:**
    *   "Why Lam Research (LRCX) Stock Is Up Today"
    *   "Lam Research Stock Soars: Time to Buy?"
    *   "LRCX: Analyst Raises Price Target to $195, Maintains Buy Rating"
    *   "Lam Research (LRCX) Stock Is Up, What You Need To Know"
    *   "Lam Research (LRCX) Stock After Hours on Dec. 15, 2025: Jefferies Lifts Target to $200"

*   **Negative News:**
    *   "Insider Sale: President and CEO of $LRCX Sells 113,300 Shares"

**Analysis:** Recent news is predominantly positive, with analysts raising price targets and positive headlines regarding the stock's performance. However, the insider sale might raise some concerns, although insider sales are common and don't always indicate a negative outlook.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~1.79)
*   **Target Price:**
    *   Average: 164.47
    *   High: 210.00
    *   Low: 84.00

**Analysis:** The analyst consensus is "Buy", with a significant range in target prices. The average target price is around the current price.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출         |
|------------|------|--------------|
| 2025-10-24 | 1.24 | 5.32 B$     |
| 2025-04-25 | 1.04 | 4.72 B$     |
| 2025-01-31 | 0.93 | 4.38 B$     |
| 2024-10-28 | 0.86 | 4.17 B$     |
| 2025-10-24 | 0.86 | 4.17 B$     |

**Analysis:** Both EPS and Revenue show a generally upward trend, indicating growth in the company's financial performance. Note that 2024-10-28 and 2025-10-24 have same values.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $5.32B  | 50.43%        |
| 2025-06-30   | $5.17B  | 50.08%        |
| 2025-03-31   | $4.72B  | 49.02%        |
| 2024-12-31   | $4.38B  | 47.37%        |
| 2024-09-30   | $4.17B  | 48.05%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-09-30   | $10.19B   | 15.39%  |
| 2025-06-30   | $9.86B    | 17.44%  |
| 2025-03-31   | $9.51B    | 13.99%  |
| 2024-12-31   | $8.81B    | 13.52%  |
| 2024-09-30   | $8.47B    | 13.18%  |

**Analysis:**

*   Revenue is increasing, and the profit margin is consistently high and even slightly increasing.
*   Equity is growing, and ROE is healthy, indicating good capital management and profitability.

**7) Comprehensive Analysis (Summary)**

Lam Research (LRCX) has significantly outperformed the S&P 500, with a high relative divergence.  Recent price action is positive, with the stock trading above its SMAs. The Market Risk Indicator suggests a medium level of risk, and the analyst consensus is a "Buy." Recent news is primarily positive, although an insider sale warrants attention. The company exhibits strong financial performance, with increasing revenue, high profit margins, growing equity, and healthy ROE. The expected return is also attractive.

**Overall:** LRCX appears to be a strong company with positive momentum, but potential investors should consider the high volatility (indicated by the high MDD) and the insider sale before making investment decisions. The divergence from the S&P 500 is near a historical high, which could suggest a potential correction.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.